Intrahippocampal Infusions of K-ATP Channel Modulators Influence Spontaneous Alternation Performance: Relationships to Acetylcholine Release in the Hippocampus
Abstract
One mechanism by which administration of glucose enhances cognitive functions may be by modulating central ATP-sensitive potassium (K-ATP) channels. K-ATP channels appear to couple glucose metabolism and neuronal excitability, with channel blockade increasing the likelihood of neurosecretion. The present experiment examined the effects of glucose and the direct K-ATP channel modulators glibenclamide and lemakalim on spontaneous alternation performance and hippocampal ACh release. Rats received either artificial CSF vehicle or vehicle plus drug for two consecutive 12 min periods via microdialysis probes (3 mm; flow rate of 2.1 μl/min) implanted in the left hippocampus. During the second 12 min period, rats were tested for spontaneous alternation performance. Dialysate was simultaneously collected for later analysis of ACh content. Both glucose (6.6 mm) and glibenclamide (100 μm) significantly increased alternation scores compared with those of controls. Conversely, lemakalim (200 μm) significantly reduced alternation scores relative to those of controls. Simultaneous administration of lemakalim with either glucose or glibenclamide resulted in alternation scores not significantly different from control values. All drug treatments enhanced hippocampal ACh output relative to control values. The results demonstrate that K-ATP channel modulators influence behavior when administered directly into the hippocampus, with channel blockers enhancing and openers impairing spontaneous alternation performance, thus supporting the hypothesis that glucose enhances memory via action at central K-ATP channels. That lemakalim, as well as glibenclamide and glucose, increased hippocampal ACh output suggests a dissociation between the effects of K-ATP channel modulators on behavior and hippocampal ACh release.
Introduction
Systemic administration ofd-glucose at doses that produce modest, physiological elevations in blood glucose levels enhance memory for aversive, appetitive, spatial, and habituation tasks in rodents (Messier and White, 1984, 1987; Gold, 1986; Messier and Destrade, 1988; Kopf and Baratti, 1994, 1996; Ragozzino et al., 1996). Central glucose injections also enhance aversive and spatial learning and memory (Lee et al., 1988; Ragozzino et al., 1998; Stefani et al., 1999). Because glucose freely crosses the blood–brain barrier, the observation that central and systemic glucose administration produce similar behavioral effects suggests a central mechanism of action. Consistent with this view, recent findings indicate that extracellular glucose levels in the hippocampus decrease during maze testing (McNay et al., 2000a,b).
Glucose may enhance memory by modulating the conductance of central ATP-sensitive potassium (K-ATP) channels. K-ATP channel conductance is decreased by increases in intracellular ATP levels and by sulfonylurea-class drugs such as glibenclamide and is increased by decreases in intracellular ATP concentration and by drugs such as lemakalim. Decreases in K-ATP channel conductance increase cellular sensitivity to depolarizing stimuli, increasing the likelihood of stimulus-evoked neurotransmitter release. K-ATP channels have been suggested as a mechanism coupling fluctuations in neuronal glucose metabolism to neurosecretion (Amoroso et al., 1990), with hyperglycemia leading to enhanced, and hypoglycemia to reduced, transmitter release.
Direct K-ATP channel modulators such as glibenclamide and lemakalim have been shown to affect neurotransmitter release both in vitro (Amoroso et al., 1990) and in vivo (During et al., 1995; Tanaka et al., 1995). Little attention has thus far been paid, however, to the effects of K-ATP channel modulators on neurotransmitter release and memory in behaving animals. In one such experiment, glibenclamide attenuated impairments of inhibitory (passive) avoidance memory produced by intraventricular injections of various K-ATP channel openers (Ghelardini et al., 1998). Results from our laboratory have shown that intraseptal injections of glibenclamide, such as glucose, enhance spontaneous alternation performance and antagonize impairments in alternation scores produced by the K-ATP channel openers morphine and galanin (Stefani and Gold, 1998; Stefani et al., 1999). Spontaneous alternation performance, which is sensitive to inter-arm delay intervals, to the number of maze arms, and to spatial cues, has been used for many years to assess spatial working memory and rates of forgetting (Zornetzer et al., 1982;Tako et al., 1988; Ragozzino et al., 1996; Caston et al., 1997; Talley et al., 2000; McNay et al., 2000a,b) (cf. Dember and Richman, 1989).
The present experiment examined the effects on spatial memory testing of direct intrahippocampal administration of glibenclamide and lemakalim to close and open, respectively, K-ATP channels. The experiment also examined interactions between lemakalim and glibenclamide and glucose on maze performance. In addition, because regulation of ACh release is a possible target for the actions of glucose (Messier et al., 1990; Kopf and Baratti, 1994, 1996; Ragozzino et al., 1994a,b, 1996, 1998; Ragozzino and Gold, 1995), the present experiment examined ACh output during spatial memory testing and drug administration.
MATERIALS AND METHODS
Subjects. Male Sprague Dawley rats (Hilltop Laboratory, Dublin, VA) weighing 275–300 gm at time of arrival were used as subjects. Thirty-six rats in total were used for the experiments described below. Rats were housed individually in a room maintained on a 12 hr light/dark cycle (lights on at 7:00 A.M.) and had ad libitum access to food and H2O. Housing and care of laboratory animals were in compliance with institutional and federal regulations.
Surgery. Rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) 20 min after the administration of atropine sulfate (108 μg/rat, i.p.). Plastic guide cannulas (model CMA/12; Carnegie Medicin, Stockholm, Sweden) directed at the hippocampus were implanted using stereotaxic coordinates derived from the atlas ofPellegrino et al. (1979) (3.8 mm caudal to bregma, 5.0 mm lateral to midline, 4.6 mm ventral from skull surface). Jeweler's screws were placed in the skull around the cannulas, and the cannulas were secured to these screws with dental acrylic (Plastics One, Roanoke, VA). Rats were permitted a 1 week recovery period, during which they were handled daily.
The tangential cannula placement, most often including portions of both dorsal and ventral hippocampus, was needed to ensure that the dialysis probe was confined to the hippocampus. Although functional differences exist between dorsal and ventral hippocampus (Hock and Bunsey, 1998;Moser and Moser, 1998; Richmond et al., 1999), there is clear evidence that the ventral hippocampus, like the dorsal hippocampus, is important for mnemonic functions (Poucet et al., 1991; Poucet and Buhot, 1994;Lorenzini et al., 1997). Importantly, there is considerable evidence indicating that the ventral, as well as dorsal, hippocampus is involved in spatial memory and that pharmacological modulation of ventral hippocampal function influences performance on tests of spatial memory (Poucet et al., 1991; Kim and Levin, 1996; Oegren et al., 1998; Levin et al., 1999).
Microdialysis. On the day of experiment, a microdialysis probe (CMA/12; Carnegie Medicin) with a dialysis surface 3 mm in length was inserted through the guide cannula and perfused continuously with vehicle solution at a rate of 2.1 μl/min for a period sufficient to achieve stable baseline ACh output (∼1 hr). Subsequent samples were collected at 12 min intervals (25 μl sample volume). The first three samples served to establish a baseline level of ACh output. Rats received either the vehicle solution or vehicle plus drug during samples 4 and 5 and then vehicle solution again for samples 6–8. Spontaneous alternation testing was conducted during the administration of sample 5. The vehicle solution was composed of (in mm): 154 NaCl, 3 KCl, 1.5 CaCl2, 1.0 MgCl2, 2.0 NaH2PO4, 2.0 Na2HPO4, and 2.0 glucose, pH 7.4. The vehicle solution also contained the acetylcholinesterase inhibitor neostigmine (1.0 μm) to enhance ACh recovery and dimethylsulfoxide (DMSO) (0.5% v/v) to ensure solubilization of the glibenclamide and lemakalim. Lemakalim was provided as a gift by SmithKline Beecham Pharmaceuticals (King of Prussia, PA). All other reagents were purchased from Sigma (St. Louis, MO).
Drug treatments were administered by reverse dialysis, with the vehicle modified to include (final concentrations) 6.6 mm glucose, 100 μm glibenclamide, and 200 μm lemakalim. Glucose and glibenclamide concentrations were selected on the basis of past findings (Ragozzino et al., 1998; Stefani et al., 1999) and pilot studies; the lemakalim concentration was selected on the basis of pilot studies indicating that this was the lowest concentration that reliably impaired spontaneous alternation scores.
Behavioral procedure. Each rat was assigned pseudorandomly to two of the following treatment groups: vehicle control (VEH), glucose (GLC), glibenclamide (GLB), lemakalim (LEM), or lemakalim plus glucose (LEM/GLC), such that no rat received the same treatment twice. The first test session was separated from the date of surgery by a 1 week interval, as was the second test session from the first. A group examining the combined effects of glibenclamide and lemakalim (LEM/GLB) was later added to the study; these rats were tested only once. Spontaneous alternation testing was conducted by placing the rat on the center platform of a four-arm radial maze (plus maze) and allowing 12 min of unimpeded exploration. The number and sequence of arm entries were recorded for calculation of a percent alternation score. An alternation consisted of 4 different arm choices of 5 consecutive arm entries. A 4/5 alternation score was computed by dividing the number of observed alternations in overlapping quintuplets by the number of possible alternations and multiplying the quotient by 100.
The plus maze was composed of four arms joined to an central platform. Each arm was 55 × 10 × 12 cm. The central platform was 25 cm across. The floor and walls of the central platform and the floors of the arms were made of gray-painted wood. The walls of the arms were made of poster board and were periodically changed to prevent the accumulation of odors. The maze floor was washed with ethanol (70% v/v) between animals.
Acetylcholine analysis. Dialysate samples (20 μl) were analyzed for ACh content by reverse-phase HPLC coupled with an enzymatic assay system and electrochemical detector. Acetylcholine and choline were separated on a reverse-phase column (Chromspher 5 C18; 100 × 3 mm; Chrompack, Middelburg, The Netherlands). A post-column enzyme reactor unit containing acetylcholinesterase (EC3.1.1.7; Sigma type VI-S) and choline oxidase (EC 1.1.3.17; Sigma) converted ACh ultimately to betaine and H2O2. Oxidation of the H2O2 was detected electrochemically using a platinum working electrode held at +525 mV relative to a silver chloride reference electrode. Acetylcholine peaks were quantified by comparison with peaks generated by ACh standards prepared at the time of each experiment. The lower detection limit of the system for ACh was 50 fmol. The mobile phase contained (in mm): 0.2 K2HPO4, 1.0 tetramethylammonium hydroxide, and 0.3 EDTA, pH 8.0, with 0.005% Kathon CG to retard bacterial growth. Mobile phase flow rate was 0.6 ml/min.
Histology. After behavioral testing, the rats were killed with an overdose of sodium pentobarbital and perfused with solutions of 0.9% NaCl and 10% formalin. Their brains were removed and stored in a 30% sucrose–10% formalin solution until sectioning. Serial sections (40-μm-thick) through the hippocampal area were mounted on glass slides and stained with cresyl violet. Stained sections were evaluated for accuracy of cannula placement. Animals with cannula placements outside of the hippocampus were excluded from subsequent analysis. Figure1 illustrates the area of the hippocampus in which cannula placements were accepted for inclusion in behavioral and neurochemical data analyses.
The shaded areas represent the extent of acceptable intrahippocampal probe placements. Animals with probe placements outside of the shaded areas were excluded from analysis. The atlas plates shown are adapted from the stereotaxic atlas of Pellegrino et al. (1979).
Statistical analysis. Behavioral data were analyzed by one-way, between-subject ANOVA with Fisher's post hoctests. Microdialysis data were analyzed by first converting raw ACh output scores for each subject to a percentage of their respective baseline ACh output. The baseline was calculated as the mean of the three samples preceding drug treatment. Within-subject comparisons of ACh output were by repeated measures ANOVA with Bonferroni correction. Between-group comparisons of ACh output for select samples were by Student's t test.
RESULTS
Histology
For all rats included here, dialysis probes were located entirely within the hippocampal formation (Fig. 1). The majority of the length of the dialysis membrane was located in the medial dentate gyrus and CA3 regions. The bottom of the dialysis membrane extended in some cases as ventral as the margin of the hippocampus and ventral subiculum.
Spontaneous alternation behavior
As shown in Figure 2, intrahippocampal infusions of K-ATP channel modulators significantly altered spontaneous alternation scores relative to those of vehicle-injected controls (F(5,39) = 17.84; p < 0.001). Glucose significantly increased spontaneous alternation scores relative to those of vehicle-infused control animals (p < 0.05), in agreement with previous findings (Ragozzino et al., 1998). Intrahippocampal infusion of the direct K-ATP channel blocker glibenclamide (100 μm) significantly increased spontaneous alternation scores relative to those of vehicle-infused control animals and glucose-infused animals (p < 0.05). Conversely, intrahippocampal infusion of the direct K-ATP channel opener lemakalim significantly decreased spontaneous alternation scores relative to vehicle-injected control animals (p< 0.05). Coadministration of either glucose or glibenclamide with lemakalim attenuated the lemakalim-induced reduction in spontaneous alternation scores; alternation scores in rats treated with glucose plus lemakalim or glibenclamide plus lemakalim did not differ from those of vehicle-infused rats (p > 0.05).
Effects on alternation scores of intrahippocampal injections of glucose, glibenclamide, lemakalim, and lemakalim plus glucose or glibenclamide. Infusion of glucose (6.6 mm) or glibenclamide (100 μm) significantly enhanced spontaneous alternation scores above those of vehicle-infused controls. Infusion of lemakalim (200 μm) significantly impaired alternation scores relative to those of controls. Coadministration of either glucose or glibenclamide and lemakalim resulted in alternation scores not significantly different from those of controls. ♦p < 0.05 versus VEH, LEM/GLC, and LEM/GLB; *p < 0.05 versus GLC. Numberswithin bars indicate the number of rats per group included in data analysis.
No significant between-group differences in the number of arm entries were observed (F(5,39) = 0.44;p = 0.82). The number of arm entries for each group were as follows (mean ± SE): VEH, 26.0 ± 1.6; GLC, 25.3 ± 1.1; GLB, 25.8 ± 2.9; LEM, 29.6 ± 2.5; LEM/GLC, 25.7 ± 2.7; and LEM/GLB, 26.0 ± 3.7. There was no significant effect of treatment order on alternation performance (p = 0.34) or number of arm entries (p = 0.15).
Hippocampal acetylcholine output
Spontaneous alternation behavior increased hippocampal ACh output in vehicle-infused rats over the baseline average (p < 0.05) (Fig.3A, sample 5). Treatment with glibenclamide, lemakalim, or lemakalim plus glucose in conjunction with maze performance significantly increased hippocampal ACh output above the level observed for vehicle-infused controls (p values < 0.05) (Fig. 3A,sample 5). Hippocampal ACh output was still significantly elevated compared with baseline levels during the 12 min time period immediately after spontaneous alternation behavior for all groups except glibenclamide and lemakalim plus glibenclamide (p values < 0.05) (Fig. 3A,sample 6). After removal of the rats from the maze to the holding cage, hippocampal ACh levels returned toward baseline levels (Fig. 3A, samples 6–8). Hippocampal ACh output after spontaneous alternation testing returned to stable levels not significantly different from baseline levels in all groups except VEH; ACh output during sample 8 was significantly lower than baseline levels (p < 0.05) (Fig. 3A,sample 8). There was no significant correlation between hippocampal ACh levels and motor activity as measured by the number of arm entries during spontaneous alternation testing (r = −0.241).
Effects of behavioral testing and drug treatments on extracellular ACh levels in the hippocampus. Drugs were administered immediately before the start of sample 4 collection. Alternation tests were conducted during sample 5. A, Time course of changes in ACh output in the hippocampus. Note that spontaneous alternation testing resulted in significant increases in hippocampal ACh output relative to baseline levels in all groups. For sample 5, *p values < 0.05 versus baseline for all groups.B, ACh output in hippocampus during behavioral testing. Note that ACh increased by 75% in vehicle controls. All drug treatments resulted in further increases in hippocampal ACh output, with increases after GLB, LEM, and LEM/GLC. ♦p < 0.05 versus VEH.
The baseline levels of ACh for each group were as follows(mean ± SEM picomoles of ACh per 25 μl sample, corrected for probe recovery): VEH, 5.1 ± 0.9; GLC, 5.0 ± 0.6; GLB, 5.0 ± 0.6; LEM, 4.3 ± 0.4; LEM/GLC, 3.6 ± 0.6; and LEM/GLB, 4.3 ± 0.5. Baseline levels of ACh did not vary significantly between groups (F(5,35) = 2.49;p = 0.42). Furthermore, the baseline levels of ACh reported here are in the range of those previously reported by this laboratory for hippocampal dialysis using perfusion fluid that did not contain the solubilizing agent DMSO (Ragozzino et al., 1994a, 1998). Thus, the DMSO used in the present study appears to have had negligible, if any, effect on basal ACh release.
DISCUSSION
Unilateral hippocampal dialysis with a solution containing either 6.6 mm glucose or 100 μm glibenclamide significantly enhanced spontaneous alternation scores relative to rats dialyzed with vehicle containing 2 mm glucose. These present findings are consistent with previous data showing that administration of glucose to the hippocampus via microdialysis enhances spontaneous alternation scores (Ragozzino et al., 1998) and extend these findings by showing that hippocampal administration of glibenclamide, which like glucose blocks K-ATP channels, also increases spontaneous alternation scores. Conversely, hippocampal dialysis with the K-ATP channel opener lemakalim (200 μm) significantly impaired spontaneous alternation performance relative to that of control animals. Both glucose and glibenclamide attenuated the performance-impairing effect of lemakalim.
The glucose metabolic product ATP and sulfonylurea-class drugs, such as glibenclamide, antagonize the effects of lemakalim on K-ATP channel function in vitro (Stanford and Lacey, 1996;Lauritzen et al., 1997, Schwanstecher and Bassen, 1997); the present results suggest that this antagonism extends as well to effects on behavior. These results are also consistent with findings obtained with intraseptal injections of glucose or glibenclamide, which enhance spontaneous alternation scores and also attenuate impairments in spontaneous alternation scores induced by the indirectly acting K-ATP channel openers morphine and galanin (Ragozzino et al., 1992; Ragozzino and Gold, 1995; Stefani and Gold, 1998; Stefani et al., 1999). Furthermore, the enhancing effects of glucose and glibenclamide on spontaneous alternation behavior are additive (Stefani et al., 1999).
Both the septal area and the hippocampus abundantly express K-ATP channels (Mourre et al., 1990, 1991), and hippocampal K-ATP channels appear to be influenced by behavioral manipulations (Fellows et al., 1993). Thus, neurons at the origin and termination of the septohippocampal pathway are potentially subject to regulation by local fluctuations in extracellular glucose levels. Decreases in extracellular glucose concentrations have been observed recently during alternation testing on a four-arm maze (McNay et al., 2000a,b), providing additional evidence that glucose availability might regulate processes important for memory processing, perhaps via K-ATP channels.
Spontaneous alternation behavior was used here as a measure of spatial working memory based on findings that performance on this task is sensitive to delay between arm choices, is dependent in part on extramaze cues, and that many potential alternative interpretations of the drug-induced impairments, such as effects on turning bias rather than on memory, are inconsistent with previous findings obtained with this same task in our laboratory and many others (Tako et al., 1988;Beracochea et al., 1989; Lalonde et al., 1993; Vaillend et al., 1995;Ragozzino et al., 1996; Caston et al., 1997; Talley et al., 2000) (cf.Dember and Richman, 1989). Also, in the present experiment, there were no significant between-group differences in the number of arm entries during the 12 min spontaneous alternation trial, suggesting that the behavioral effects of the drug treatments were attributable to an influence on mnemonic processes rather than an effect on general motor activity or to differences in inter-arm, i.e., intertrial, interval. A mnemonic effect of K-ATP channel modulators is also supported by the finding that intraventricular administration of several K-ATP channel openers impairs memory for inhibitory avoidance training and that glibenclamide attenuates these impairments (Ghelardini et al., 1998).
The present study also examined the effects of K-ATP channel modulators on hippocampal ACh release in conjunction with spontaneous alternation testing. Substantial evidence, assessed thus far primarily in the hippocampus, indicates that glucose may enhance memory by augmenting cholinergic functions (Messier et al., 1990; Durkin et al., 1992;Ragozzino et al., 1994a; Micheau et al., 1995). Maze performance per se significantly increases hippocampal ACh output above baseline levels; acute glucose administration further increases this behavior-dependent ACh release (Ragozzino et al., 1994a, 1996, 1998; present data). In the present study, both glucose and glibenclamide administration augmented the increase in hippocampal ACh outputs seen in controls. Unlike previous studies, however, the increase after glucose administration was not significant, although it approached significance. One difference between the previous and present studies is that vehicle-infused rats in the present studies had a higher behavior-induced increase in ACh output, as well as higher control alternation scores compared with those in past studies that used the same behavioral apparatus (Ragozzino et al., 1996, 1998).
In previous studies, glucose attenuated decreases in hippocampal ACh release caused by systemic and intraseptal injections of the opioid receptor agonist and indirect K-ATP channel opener morphine (Ragozzino et al., 1994a; Ragozzino and Gold, 1995); these neurochemical results paralleled attenuation by glucose of morphine-induced impairments in alternation performance. In contrast, the present findings show that hippocampal dialysis with lemakalim, alone or in combination with glucose or glibenclamide, increased behavior-dependent hippocampal ACh release above control levels, with the highest levels of hippocampal ACh release seen in the groups receiving lemakalim alone or in combination with glucose. Thus, although most conditions resulted in relationships between ACh release and memory consistent with previous findings, there was a dissociation between spontaneous alternation scores and hippocampal ACh release after administration of lemakalim. The different findings may reflect different and perhaps multiple sites of action of morphine and lemakalim with respect to ACh participation in memory. One interpretation of the findings is that morphine acts before the contribution of ACh to memory processing and that lemakalim acts at a step beyond the contribution of ACh to memory processing. According to this interpretation, ACh release would be associated with learning and memory for manipulations acting before or at cholinergic mechanisms but would not be associated with learning and memory for manipulations acting thereafter. Note, however, that this is a description of perhaps the simplest condition. More likely, multiple neurotransmitters contribute to memory processing in parallel. Consistent with the possibility that regulation of K-ATP channels may influence many neurotransmitters are the effects seen on GABA, dopamine, serotonin, and glutamate (Mourre et al., 1991;Zetterström et al., 1991; During et al., 1995; Tanaka et al., 1995; Lee et al., 1996). Of these neurotransmitter systems, glucose effects on memory have been examined and observed as interactions with drugs directed at GABA and glutamate receptors (Walker and Gold, 1992;Lennartz and Gold, 1995; Parent and Gold, 1997; Parent et al., 1997). If the effects on memory of glucose and K-ATP channel modulators are through multiple neurochemical systems, characterization of the relative contributions of these different neurotransmitters to memory processing will require examination of release of multiple neurotransmitters while rats are performing memory tasks under many different drug conditions.
In conclusion, the present data demonstrate that central administration of K-ATP channel modulators influence spatial memory, with channel blockers enhancing and channel openers impairing spontaneous alternation behavior. Thus, the data provide further support for the hypothesis that glucose enhances memory via modulation of K-ATP channel conductance. Because K-ATP channel activity is regulated by intracellular ATP concentrations (Panten et al., 1996), K-ATP channels may couple neurosecretion to neuronal glucose metabolism (Amoroso et al., 1990). According to this view, increases in glucose may enhance stimulus-evoked transmitter release, thereby providing an attractive mechanism by which peripheral and central glucose administration enhances cognitive functions. Further experiments examining the effects of glucose and direct K-ATP channel modulators on behavior-dependent neurotransmitter release will clarify the system(s) through which glucose exerts its mnemonic effects.
Footnotes
- Received May 16, 2000.
- Revision received October 2, 2000.
- Accepted October 12, 2000.
-
This work was supported by National Institute on Aging Grant AG07648, National Institute of Neurological Disorders and Stroke Grant NS32914, United States Department of Agriculture Grant 00-35200-9059, and a research grant from the Alzheimer Association. M.R.S. was supported by National Institute of Mental Health predoctoral fellowship Grant MH11057. We thank SmithKline Beecham Pharmaceuticals for their donation of lemakalim and Thomas Fries for his technical assistance.
Correspondence should be addressed to Dr. Paul E. Gold, Department of Psychology, University of Illinois at Urbana-Champaign, 603 East Daniel Street, Champaign, IL 61820. E-mail: pgold{at}uiuc.edu.
- Copyright © 2001 Society for Neuroscience
